Hemostemix Inc (OTC:HMTXF) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Desiree Cox | Director · Since May 25, 2026 |
| Fraser Henderson | Chief Medical Officer · Since at least Jan 16, 2026 |
| John M. Viglotti | SVP Corporate Services · Sep 18, 2025 – Nov 4, 2026 · Past |
| Loran Swanberg | Director · Since at least Jul 31, 2025 |
| Peter Lacey | Chairman of the Board · Since at least Mar 9, 2026 |
| Ronnie Hershman | Director · Since at least Nov 4, 2026 |
| Shaune Harding | Director of Patient Care & Clinical Operations · Since at least Dec 4, 2025 |
| Thomas Smeenk | President & CEO. Co-Founder · Since at least Oct 7, 2026 |